Pharmaceuticals
US7691877B2 · kind B2 · utility
25Cited by
0References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 16, 2007 |
| Grant date | Apr 6, 2010 |
| Priority date | — |
| Expiry date | Jul 23, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to immune response modifiers of formula (I), which act selectively through agonism, of Toll-Like Receptors (TLRs), uses thereof, processes for the preparation thereof, intermediates used in the preparation thereof and compositions containing said inhibitors. These inhibitors have utility in a variety of therapeutic areas including the treatment of infectious disease such as Hepatitis (e.g. HCV, HBV), genetically related viral infection and cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.